论文部分内容阅读
自主性功能性甲状腺腺瘤又称甲状腺毒性腺瘤,与Graves 病不同。自主性功能性甲状腺腺瘤病因迄今未明,元伴甲亢症状者随时间推移,每年有5%发展为甲状腺功能亢进。早期治疗甚为必要。本科自1998年1月~2003年1月,应用~(131)I 治疗该病共38例,现报道如下。1 资料与方法1.1 一般资料:以自1998年1月~2003年1月间确诊为最大直径<3cm 之早期自主性功能性甲状腺腺瘤的38例患者行(131)I 治疗,其中男14例,女24例,年龄28~67岁,平均(46.82±11.65)岁。随诊时间12~24个月,平均(18.64±5.82)个月。1.2 治疗方法:患者均行甲状腺细针穿刺活组织检查
Autonomous functional thyroid adenoma, also known as thyroid adenoma, and Graves disease is different. Autonomous functional thyroid adenoma etiology so far unknown, with symptoms of hyperthyroidism over time, each year 5% of the development of hyperthyroidism. Early treatment is necessary. Undergraduate from January 1998 ~ January 2003, the application of 131I treatment of the disease a total of 38 cases, are reported below. 1 Materials and Methods 1.1 General Information: From January 1998 to January 2003 confirmed the largest diameter <3cm of 38 patients with early-independent functional thyroid adenoma (131) I treatment, including 14 males , 24 females, aged 28 to 67 years, mean (46.82 ± 11.65) years. Follow-up time of 12 to 24 months, an average of (18.64 ± 5.82) months. 1.2 treatment: patients underwent thyroid fine needle biopsy